Aaron Kesselheim (2009 Awardee) was quoted in "FDA has free-speech, safety issues to weigh in review of ‘off-label’ drug marketing rules" on the Washington Post and "Some Generic Drugs Contribute to Rising Health Care Costs, too" on the Wall Street Journal Pharmalot blog, both published July 9, 2014.
News Source:
Date:
Wednesday, July 9, 2014
Investigator: